Prostate cancer screening with prostate-specific antigen (PSA) test: A clinical practice guideline

Autor: Per Olav Vandvik, Kari A.O. Tikkinen, Lyubov Lytvyn, Johanna Sommer, Reto Auer, Philipp Dahm, Bill Vaughan, Anja Fog Heen, Reed A C Siemieniuk, Jérôme Stirnemann, Thomas Agoritsas, Russell Wheeler, Awah Cletus Fobuzi, Robin W.M. Vernooij, Manabu Yoshimura, Marco H. Blanker, Helen Macdonald, Noelle Perron Junod, Gordon H. Guyatt

Publikováno v: BMJ-British Medical Journal, 362:3581. BMJ PUBLISHING GROUP
Tikkinen, Kari A O; Dahm, Philipp; Lytvyn, Lyubov; Heen, Anja F; Vernooij, Robin W M; Siemieniuk, Reed A C; Wheeler, Russell; Vaughan, Bill; Fobuzi, Awah Cletus; Blanker, Marco H; Junod, Noelle; Sommer, Johanna; Stirnemann, Jérôme; Yoshimura, Manabu; Auer, Reto; MacDonald, Helen; Guyatt, Gordon; Vandvik, Per Olav; Agoritsas, Thomas (2018). Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline. BMJ, 362, k3581. BMJ Publishing Group 10.1136/bmj.k3581
BMJ, Vol. 362 (2018) P. k3581
BMJ
The BMJ

What is the role of prostate-specific antigen (PSA) screening in prostate cancer? An expert panel produced these recommendations based on a linked systematic review.1 The review was triggered by a large scale, cluster randomised trial on PSA screenin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e62cc5f2d212b78d19f46d56b3f3f358
https://research.rug.nl/en/publications/42e07b2e-191f-48d8-b4bf-ed61bf774e5e